International Assets Investment Management LLC Takes $204,000 Position in Abrdn Life Sciences Investors (NYSE:HQL)

International Assets Investment Management LLC purchased a new stake in shares of Abrdn Life Sciences Investors (NYSE:HQL) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 13,507 shares of the company’s stock, valued at approximately $204,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of HQL. Karpus Management Inc. purchased a new stake in shares of Abrdn Life Sciences Investors in the 1st quarter worth $4,709,000. Cetera Investment Advisers increased its stake in shares of Abrdn Life Sciences Investors by 6.9% in the 2nd quarter. Cetera Investment Advisers now owns 156,384 shares of the company’s stock worth $2,216,000 after purchasing an additional 10,137 shares in the last quarter. Advisors Asset Management Inc. increased its stake in shares of Abrdn Life Sciences Investors by 21.2% in the 1st quarter. Advisors Asset Management Inc. now owns 149,184 shares of the company’s stock worth $2,033,000 after purchasing an additional 26,107 shares in the last quarter. Cetera Advisors LLC purchased a new stake in shares of Abrdn Life Sciences Investors in the 1st quarter worth $1,929,000. Finally, 180 Wealth Advisors LLC increased its stake in shares of Abrdn Life Sciences Investors by 2.8% in the 2nd quarter. 180 Wealth Advisors LLC now owns 136,231 shares of the company’s stock worth $2,013,000 after purchasing an additional 3,682 shares in the last quarter. 32.21% of the stock is owned by institutional investors.

Abrdn Life Sciences Investors Stock Performance

NYSE:HQL opened at $14.97 on Thursday. Abrdn Life Sciences Investors has a one year low of $11.62 and a one year high of $15.90. The business has a fifty day moving average price of $15.03 and a 200-day moving average price of $14.57.

Abrdn Life Sciences Investors Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Friday, August 23rd were paid a $0.49 dividend. This represents a $1.96 dividend on an annualized basis and a yield of 13.09%. The ex-dividend date of this dividend was Friday, August 23rd. This is a positive change from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.48.

Abrdn Life Sciences Investors Company Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.